Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study
Petr Zatloukal, Lubos B. Petruzelka, Milada Zemanová et al. · Lung Cancer · 2004
Cited by 427 works. doi:10.1016/j.lungcan.2004.03.004
Authors
- Petr Zatloukal
- Lubos B. Petruzelka
- Milada Zemanová
- Libor Havel
- Filip Jankú
- Libor Judas
- A Kubík
- Evzen Krepela
- Pavel Fiala
- Ladislav Pecen
References
- Nonparametric Estimation from Incomplete Observations
- Nonparametric Estimation from Incomplete Observations
- TNM Classification of Malignant Tumours
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
- Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
- American Society of Clinical Oncology
- Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
- Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer